Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

456 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both.
Woodcock J, LaVange LM. Woodcock J, et al. N Engl J Med. 2017 Jul 6;377(1):62-70. doi: 10.1056/NEJMra1510062. N Engl J Med. 2017. PMID: 28679092 No abstract available.
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials.
O'Shaughnessy JA, Wittes RE, Burke G, Friedman MA, Johnson JR, Niederhuber JE, Rothenberg ML, Woodcock J, Chabner BA, Temple R. O'Shaughnessy JA, et al. Among authors: woodcock j. J Clin Oncol. 1991 Dec;9(12):2225-32. doi: 10.1200/JCO.1991.9.12.2225. J Clin Oncol. 1991. PMID: 1960563
Regulation of somatic-cell therapy and gene therapy by the food and drug administration.
Kessler DA, Siegel JP, Noguchi PD, Zoon KC, Feiden KL, Woodcock J. Kessler DA, et al. Among authors: woodcock j. N Engl J Med. 1993 Oct 14;329(16):1169-73. doi: 10.1056/NEJM199310143291607. N Engl J Med. 1993. PMID: 8377782 Review. No abstract available.
Keynote address.
Woodcock J. Woodcock J. J Nutr. 1999 Jan;129(1S Suppl):225S-226S. doi: 10.1093/jn/129.1.225S. J Nutr. 1999. PMID: 9915904 No abstract available.
Pharmacogenomic-guided drug development: regulatory perspective.
Lesko LJ, Woodcock J. Lesko LJ, et al. Among authors: woodcock j. Pharmacogenomics J. 2002;2(1):20-4. doi: 10.1038/sj.tpj.6500046. Pharmacogenomics J. 2002. PMID: 11990376 No abstract available.
Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective.
Lesko LJ, Woodcock J. Lesko LJ, et al. Among authors: woodcock j. Nat Rev Drug Discov. 2004 Sep;3(9):763-9. doi: 10.1038/nrd1499. Nat Rev Drug Discov. 2004. PMID: 15340386 Review.
FDA introductory comments: clinical studies design and evaluation issues.
Woodcock J. Woodcock J. Clin Trials. 2005;2(4):273-5. doi: 10.1191/1740774505cn096oa. Clin Trials. 2005. PMID: 16281424 No abstract available.
Stimulating the development of mechanism-based, individualized pain therapies.
Woodcock J, Witter J, Dionne RA. Woodcock J, et al. Nat Rev Drug Discov. 2007 Sep;6(9):703-10. doi: 10.1038/nrd2335. Nat Rev Drug Discov. 2007. PMID: 17762885 Review.
Molecular medicine: how, what, and when?
Woodcock J. Woodcock J. Clin Pharmacol Ther. 2007 Oct;82(4):376-8. doi: 10.1038/sj.clpt.6100349. Clin Pharmacol Ther. 2007. PMID: 17851578
The FDA critical path initiative and its influence on new drug development.
Woodcock J, Woosley R. Woodcock J, et al. Annu Rev Med. 2008;59:1-12. doi: 10.1146/ Annu Rev Med. 2008. PMID: 18186700 Review.
456 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page